Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines?
By: Pawan Dutt and Tanel Kerikmäe
Authors
Pawan Dutt
Lecturer at Chair of Law and Technology, Tallinn Law School, Faculty of Social Sciences, Tallinn University of Technology,, Tallinn, Estonia
Tanel Kerikmäe
Professor and head of the Jean Monnet Chair of European Law, Tallinn Law School, Faculty of Social Sciences, Tallinn University of Technology,, Tallinn, Estonia
Language: English
Page range: 23 - 38
Published on: Jan 24, 2018
Published by: Palacký University Olomouc
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2018 Pawan Dutt, Tanel Kerikmäe, published by Palacký University Olomouc
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.